Skip to main
PRE

PRE Stock Forecast & Price Target

PRE Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Prenetics Global is a strong investment opportunity with a successful supplement brand, steady increase in annual revenue rate, well-established marketing channels, and potential for break-even in the near future. With financing from General Catalyst, their focus on marketing and product expansion is likely to lead to continued revenue growth. Additionally, partnerships with influencers and a successful clinical trial signal the company's commitment to quality and customer satisfaction. While competition exists in the market, Prenetics' promising financial outlook and projected revenue growth make it a potentially lucrative investment.

Bears say

Prenetics Global is facing financial challenges due to its high sales and marketing expenses, particularly related to customer acquisition costs. While the gross margins of its flagship brand, IM8, have improved, the company's recent shift towards longer-duration quarterly subscribers has increased per-customer acquisition costs. Additionally, the company's global shipping costs could also potentially impact its profitability in the face of changing global shipping rates.

PRE has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Prenetics Global Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Prenetics Global Ltd (PRE) Forecast

Analysts have given PRE a Strong Buy based on their latest research and market trends.

According to 3 analysts, PRE has a Strong Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Prenetics Global Ltd (PRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.